Thus, in general, a more clinically symptomatic disease is likely to be associated to the presence of STAT3 mutations and the evidence that neutropenia is more detectable in more severely affected patients suggests that STAT3 aberrancies might be responsible. This evidence concerns the gene STAT3 and neutropenia.